UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 150

Sortiert nach

SARS-CoV-2 Spike Protein Expression In Vitro and Hematologic Effects in Mice Vaccinated With AZD1222 (ChAdOx1 nCoV-19)

Frontiers in immunology, 2022-04, Vol.13, p.836492

2022

Volltextzugriff (PDF)

Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1 Inhibition in Type 2 Diabetes: Phase 1 Results

Journal of the American Heart Association, 2023-02, Vol.12 (3), p.e027540

2023

Volltextzugriff (PDF)

Synthetic LXR Ligand Inhibits the Development of Atherosclerosis in Mice

Proceedings of the National Academy of Sciences - PNAS, 2002-05, Vol.99 (11), p.7604-7609

2002

Volltextzugriff (PDF)

AZD1222 (ChAdOx1 nCov-19): A Single-Dose biodistribution study in mice

Vaccine, 2022-01, Vol.40 (2), p.192-195

2022

Volltextzugriff (PDF)

Developmental and reproductive safety of AZD1222 (ChAdOx1 nCoV-19) in mice

Reproductive toxicology (Elmsford, N.Y.), 2021-09, Vol.104, p.134-142

2021

Volltextzugriff (PDF)

European Bioanalysis Forum recommendation on singlicate analysis for ligand binding assays: time for a new mindset

Bioanalysis, 2020-03, Vol.12 (5), p.273-284

2020

Volltextzugriff (PDF)

Analytical assay platforms for soluble target engagement biomarkers: old favorites and emerging technologies

Bioanalysis, 2013-12, Vol.5 (23), p.2919-2931

2013

Volltextzugriff (PDF)

Engineering the surface properties of a human monoclonal antibody prevents self-association and rapid clearance in vivo

Scientific reports, 2016-12, Vol.6 (1), p.38644, Article 38644

2016

Volltextzugriff (PDF)

European Bioanalysis Forum feedback on draft ICH M10 guideline on bioanalytical method validation during the Step 2b public consultation period

Bioanalysis, 2020-03, Vol.12 (6s), p.1

2020

Volltextzugriff (PDF)

Toward decision-based acceptance criteria for Bioanalytical Method Validation: a proposal for discussion from the European Bioanalysis Forum

Bioanalysis, 2018-08, Vol.10 (16), p.1255-1259

2018

Volltextzugriff (PDF)

Update to the European Bioanalysis Forum recommendation on biomarkers assays; bringing context of use into practice

Bioanalysis, 2020-10, Vol.12 (20), p.1427-1437

2020

Volltextzugriff (PDF)

European Bioanalysis Forum feedback on draft ICH M10 guideline on bioanalytical method validation during the Step 2b public consultation period

Bioanalysis, 2020-03, Vol.12 (6s), p.1-11

2020

Volltextzugriff (PDF)

Conference Report from the European Bioanalysis Forum Workshop: toward harmonized implementation of the ICH M10 guideline

Bioanalysis, 2022-11, Vol.14 (22), p.1407-1411

2022

Volltextzugriff (PDF)

Developing an injectable co-formulation of two antidiabetic drugs: Excipient impact on peptide aggregation and pharmacokinetic properties

International journal of pharmaceutics, 2020-02, Vol.576, p.119019, Article 119019

2020

Volltextzugriff (PDF)

Discovery and characterization of GSK256073, a non-flushing hydroxy-carboxylic acid receptor 2 (HCA2) agonist

European journal of pharmacology, 2015-06, Vol.756, p.1-7

2015

Volltextzugriff (PDF)

A strategic approach to nonclinical immunogenicity assessment: a recommendation from the European Bioanalysis Forum

Bioanalysis, 2021-04, Vol.13 (7), p.537-549

2021

Volltextzugriff (PDF)

Recommendations and discussion points on immunogenicity, biomarkers, automation/technology and protein–MS from the 2021 European Bioanalysis Forum Focus Workshops

Bioanalysis, 2021-10, Vol.13 (19), p.1459-1465

2021

Volltextzugriff (PDF)

Biomarker context-of-use: how organizational design can impact the implementation of the appropriate biomarker assay strategy

Bioanalysis, 2022-07, Vol.14 (13), p.911-917

2022

Volltextzugriff (PDF)

EBF recommendation on practical management of critical reagents for PK ligand-binding assays

Bioanalysis, 2018-10, Vol.10 (19), p.1557-1565

2018

Volltextzugriff (PDF)

EBF recommendation on practical management of critical reagents for antidrug antibody ligand-binding assays

Bioanalysis, 2019-10, Vol.11 (19), p.1787-1798

2019

Volltextzugriff (PDF)

Addressing the challenges of biomarker calibration standards in ligand-binding assays: a European Bioanalysis Forum perspective

Bioanalysis, 2017-10, Vol.9 (19), p.1493-1508

2017

Volltextzugriff (PDF)

Feedback from the European Bioanalysis Forum: focus workshop on current analysis of immunogenicity: best practices and regulatory hurdles

Bioanalysis, 2018-02, Vol.10 (4), p.197-204

2018

Volltextzugriff (PDF)

Pain management documentation: The effects of the perception of the practice environment and clinical expertise

Samuels, Joanne Goodman

2007

Volltextzugriff (PDF)

Intramuscular injection of a plasmid vector expressing human apolipoprotein E limits progression of xanthoma and aortic atheroma in apoE-deficient mice

Human molecular genetics, 2000-10, Vol.9 (17), p.2545-2551

2000

Volltextzugriff (PDF)

The jewel in Pilkington's crown. (Barr and Stroud; information technology and personnel reforms have bolstered Pilkington's defense manufacturer subsidiary)

Computer weekly, 1994-04, p.48

Goodman, Joanne

1994

Volltextzugriff (PDF)

1 – 25 von 150

Suche als RSS-Feed

Aktive Filter

KollektionEBSCOhost Business Source Ultimate

KollektionNexis

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(138)
Mit Volltextzugriff
(137)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

SARS-CoV-2 Spike Protein Expression In Vitro and Hematologic Effects in Mice Vaccinated With AZD1222 (ChAdOx1 nCoV-19)

Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1 Inhibition in Type 2 Diabetes: Phase 1 Results

Synthetic LXR Ligand Inhibits the Development of Atherosclerosis in Mice

AZD1222 (ChAdOx1 nCov-19): A Single-Dose biodistribution study in mice

Developmental and reproductive safety of AZD1222 (ChAdOx1 nCoV-19) in mice

European Bioanalysis Forum recommendation on singlicate analysis for ligand binding assays: time for a new mindset

Analytical assay platforms for soluble target engagement biomarkers: old favorites and emerging technologies

Engineering the surface properties of a human monoclonal antibody prevents self-association and rapid clearance in vivo

European Bioanalysis Forum feedback on draft ICH M10 guideline on bioanalytical method validation during the Step 2b public consultation period

Toward decision-based acceptance criteria for Bioanalytical Method Validation: a proposal for discussion from the European Bioanalysis Forum

Update to the European Bioanalysis Forum recommendation on biomarkers assays; bringing context of use into practice

European Bioanalysis Forum feedback on draft ICH M10 guideline on bioanalytical method validation during the Step 2b public consultation period

Conference Report from the European Bioanalysis Forum Workshop: toward harmonized implementation of the ICH M10 guideline

Developing an injectable co-formulation of two antidiabetic drugs: Excipient impact on peptide aggregation and pharmacokinetic properties

Discovery and characterization of GSK256073, a non-flushing hydroxy-carboxylic acid receptor 2 (HCA2) agonist

A strategic approach to nonclinical immunogenicity assessment: a recommendation from the European Bioanalysis Forum

Recommendations and discussion points on immunogenicity, biomarkers, automation/technology and protein–MS from the 2021 European Bioanalysis Forum Focus Workshops

Biomarker context-of-use: how organizational design can impact the implementation of the appropriate biomarker assay strategy

EBF recommendation on practical management of critical reagents for PK ligand-binding assays

EBF recommendation on practical management of critical reagents for antidrug antibody ligand-binding assays

Addressing the challenges of biomarker calibration standards in ligand-binding assays: a European Bioanalysis Forum perspective

Feedback from the European Bioanalysis Forum: focus workshop on current analysis of immunogenicity: best practices and regulatory hurdles

Pain management documentation: The effects of the perception of the practice environment and clinical expertise

Intramuscular injection of a plasmid vector expressing human apolipoprotein E limits progression of xanthoma and aortic atheroma in apoE-deficient mice

The jewel in Pilkington's crown. (Barr and Stroud; information technology and personnel reforms have bolstered Pilkington's defense manufacturer subsidiary)

Aktive Filter

Suchergebnisse filtern